| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 47.16B | 47.29B | 42.82B | 38.61B | 43.96B | 39.67B |
| Gross Profit | 10.20B | 10.06B | 9.49B | 8.63B | 8.93B | 9.59B |
| EBITDA | 3.67B | 2.87B | 2.11B | 1.83B | 2.48B | 2.59B |
| Net Income | 1.84B | 1.77B | 1.21B | 1.10B | 1.49B | 1.54B |
Balance Sheet | ||||||
| Total Assets | 19.49B | 20.18B | 18.07B | 16.93B | 16.09B | 16.77B |
| Cash, Cash Equivalents and Short-Term Investments | 5.53B | 5.97B | 3.77B | 3.25B | 2.51B | 2.54B |
| Total Debt | 370.00M | 399.00M | 654.00M | 1.07B | 1.61B | 2.20B |
| Total Liabilities | 7.33B | 8.22B | 7.66B | 7.52B | 7.56B | 7.82B |
| Stockholders Equity | 12.05B | 11.84B | 10.31B | 9.32B | 8.45B | 8.89B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.70B | 1.14B | 1.53B | 758.00M | 1.09B |
| Operating Cash Flow | 0.00 | 2.94B | 1.43B | 1.83B | 996.00M | 1.35B |
| Investing Cash Flow | 0.00 | -604.00M | -316.00M | -710.00M | -606.00M | -650.00M |
| Financing Cash Flow | 0.00 | -498.00M | -628.00M | -771.00M | -816.00M | -215.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥220.11B | 7.63 | 14.97% | 2.94% | 9.67% | 45.58% | |
80 Outperform | ¥11.65B | 5.21 | ― | 2.48% | 11.56% | 56.86% | |
74 Outperform | ¥54.37B | 19.94 | ― | 4.12% | -4.88% | -26.05% | |
72 Outperform | ¥14.71B | 9.00 | ― | 4.62% | -2.98% | 4.56% | |
65 Neutral | ¥33.03B | 11.35 | ― | 5.16% | 1.71% | -29.37% | |
64 Neutral | ¥31.90B | 101.97 | 1.55% | 1.34% | -34.13% | -31.24% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |